Patents by Inventor Susan Murray

Susan Murray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense modulation of CD40 ligand expression
    Publication number: 20060160758
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of CD40 ligand. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD40 ligand. Methods of using these compounds for modulation of CD40 ligand expression and for treatment of diseases associated with expression of CD40 ligand are provided.
    Type: Application
    Filed: January 20, 2005
    Publication date: July 20, 2006
    Inventors: C. Bennett, Susan Freier, Brenda Baker, Brett Monia, Nicholas Dean, Hong Zhang, Susan Murray, Lex Cowsert, Madeline Butler, Robert McKay, Donna Ward, William Gaarde, Ian Popoff, Jacqueline Wyatt, Andrew Watt
  • Antisense modulation of p70 S6 kinase expression
    Publication number: 20050267063
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of p70 S6 kinase. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding p70 S6 kinase. Methods of using these compounds for modulation of p70 S6 kinase expression and for treatment of diseases associated with expression of p70 S6 kinase are provided.
    Type: Application
    Filed: April 27, 2005
    Publication date: December 1, 2005
    Inventors: C. Bennett, Brett Monia, Susan Freier, Brenda Baker, William Gaarde, Erich Koller, Susan Murray, Andrew Watt, Jacqueline Wyatt, Pamela Nero, Mark Roach, Lex Cowsert, Kenneth Dobie
  • Antisense modulation of TFAP2C expression
    Publication number: 20050227938
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of TFAP2C. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TFAP2C. Methods of using these compounds for modulation of TFAP2C expression and for treatment of diseases associated with expression of TFAP2C are provided.
    Type: Application
    Filed: December 17, 2004
    Publication date: October 13, 2005
    Inventors: C. Bennett, Brenda Baker, Nicholas Dean, Brett Monia, Susan Freier, James Karras, Hong Zhang, Susan Murray, Madeline Butler, Erich Koller, Thomas Condon, William Gaarde, Andrew Watt, Mark Graham, Jacqueline Wyatt, Lex Cowsert, Kenneth Dobie, Mark Roach
  • Antisense modulation of interferon gamma receptor 2
    Publication number: 20050153924
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Interferon gamma receptor 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Interferon gamma receptor 2. Methods of using these compounds for modulation of Interferon gamma receptor 2 expression and for treatment of diseases associated with expression of Interferon gamma receptor 2 are provided.
    Type: Application
    Filed: December 15, 2004
    Publication date: July 14, 2005
    Inventors: C. Bennett, Brett Monia, Susan Murray, Madeline Butler, Nicholas Dean, Rosanne Crooke, Mark Graham, Hong Zhang, Susan Freier, Brenda Baker, Eric Marcusson, Jacqueline Wyatt, Lex Cowsert, Kenneth Dobie, Andrew Watt
  • Antisense modulation of transforming growth factor beta receptor II expression
    Publication number: 20040147472
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Transforming growth factor beta receptor II. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Transforming growth factor beta receptor II. Methods of using these compounds for modulation of Transforming growth factor beta receptor II expression and for treatment of diseases associated with expression of Transforming growth factor beta receptor II are provided.
    Type: Application
    Filed: November 10, 2003
    Publication date: July 29, 2004
    Inventors: Susan Murray, Jacqueline Wyatt
  • Antisense modulation of PI3K P85 Expression
    Publication number: 20040077580
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of PI3K p85. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PI3K p85. Methods of using these compounds for modulation of PI3K p85 expression and for treatment of diseases associated with expression of PI3K p85 are provided.
    Type: Application
    Filed: November 7, 2003
    Publication date: April 22, 2004
    Inventors: Brett P. Monia, Lex M. Cowsert, Susan Murray, Madeline M. Butler, Nicholas M. Dean
  • Antisense modulation of transforming growth factor-beta expression
    Publication number: 20040063655
    Abstract: Compositions and methods are provided for inhibiting the expression of TGF-&bgr;2. Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TGF-&bgr;2 are preferred. Methods of using these compounds for modulation of TGF-&bgr;2 expression and for treatment of diseases associated with expression of TGF-&bgr; are also provided.
    Type: Application
    Filed: August 1, 2003
    Publication date: April 1, 2004
    Inventors: Nicholas M. Dean, Susan Murray
  • Antisense modulation of transforming growth factor beta receptor II expression
    Publication number: 20030064944
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Transforming growth factor beta receptor II. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Transforming growth factor beta receptor II. Methods of using these compounds for modulation of Transforming growth factor beta receptor II expression and for treatment of diseases associated with expression of Transforming growth factor beta receptor II are provided.
    Type: Application
    Filed: June 21, 2001
    Publication date: April 3, 2003
    Applicant: Isis Pharmaceuticals Inc.
    Inventors: Susan Murray, Jacqueline Wyatt
  • Antisense modulation of transforming growth factor-beta expression
    Publication number: 20030050265
    Abstract: Compositions and methods are provided for inhibiting the expression of TGF-&bgr;2. Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TGF-&bgr;2 are preferred. Methods of using these compounds for modulation of TGF-&bgr;2 expression and for treatment of diseases associated with expression of TGF-&bgr; are also provided.
    Type: Application
    Filed: September 5, 2001
    Publication date: March 13, 2003
    Inventors: Nicholas M. Dean, Susan Murray
  • Antisense modulation of macrophage migration inhibitory factor expression
    Patent number: 6268151
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Macrophage migration inhibitory factor. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Macrophage migration inhibitory factor. Methods of using these compounds for modulation of Macrophage migration inhibitory factor expression and for treatment of diseases associated with expression of Macrophage migration inhibitory factor are provided.
    Type: Grant
    Filed: January 20, 2000
    Date of Patent: July 31, 2001
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Susan Murray, Lex M. Cowsert, Jacqueline Wyatt